Cytotoxic drug sensitivity of Epstein-Barr virus transformed lymphoblastoid B-cells
2006

Drug Sensitivity of EBV Transformed B-Cells

Sample size: 17 publication Evidence: moderate

Author Information

Author(s): Markasz Laszlo, Stuber György, Flaberg Emilie, Jernberg Åsa Gustafsson, Eksborg Staffan, Olah Eva, Skribek Henriette, Szekely Laszlo

Primary Institution: Karolinska Institute

Hypothesis

What are the most effective cytotoxic drugs against EBV-induced lymphoproliferations?

Conclusion

The study suggests that including epirubicin and paclitaxel in chemotherapy protocols for PTLD may be beneficial.

Supporting Evidence

  • LCLs showed similar drug sensitivity patterns against 29 cytostatic drugs.
  • LCLs were highly sensitive to vincristine, methotrexate, epirubicin, and paclitaxel.
  • The study involved over 6500 cell survival and proliferation assays.

Takeaway

This study looked at how well different cancer drugs work on certain types of cells infected with a virus. They found that some drugs work really well.

Methodology

The study assessed 17 lymphoblastoid cell lines for drug sensitivity using a 3-day cell culture and fluorescent staining to count live and dead cells.

Limitations

The study does not include controlled trials or a diverse patient population.

Digital Object Identifier (DOI)

10.1186/1471-2407-6-265

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication